vestronidase alfa
Generic: vestronidase alfa·Brand: Mepsevii
vestronidase alfa: sourced relationships with 1 company · 1 clinical trial tracked.
vestronidase alfa evidence translation
What we can confirm
1 tracked trial
What it means
Source-backed records connect vestronidase alfa to RARE; that link alone does not prove the drug works.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
How could vestronidase alfa → RARE affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
MPS VII
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) MPS VII | Approved |
Clinical Trial Registry Records (1)
Expanded Access to Mepsevii
Expanded AccessUltragenyx Pharmaceutical Inc
Frequently asked questions
Which companies have sourced relationships with vestronidase alfa?
vestronidase alfa has dated SEC/FDA relationship records for Ultragenyx Pharmaceutical Inc..
How many clinical trials involve vestronidase alfa?
BioSniper tracks 1 clinical trial involving vestronidase alfa.